Open this publication in new window or tab >>Show others...
2023 (English)In: Journal of Biological Chemistry, ISSN 0021-9258, E-ISSN 1083-351X, Vol. 299, no 10, article id 105256Article in journal (Refereed) Published
Abstract [en]
The glycosyltransferase WaaG in Pseudomonas aeruginosa (PaWaaG) is involved in the synthesis of the core region of lipopolysaccharides. It is a promising target for developing adjuvants that could help in the uptake of antibiotics. Herein, we have determined structures of PaWaaG in complex with the nucleotide-sugars UDP-glucose, UDP-galactose, and UDP-GalNAc. Structural comparison with the homolog from Escherichia coli (EcWaaG) revealed five key differences in the sugar-binding pocket. Solution-state NMR analysis showed that WT PaWaaG specifically hydrolyzes UDP-GalNAc and unlike EcWaaG, does not hydrolyze UDP-glucose. Furthermore, we found that a PaWaaG mutant (Y97F/T208R/N282A/T283A/T285I) designed to resemble the EcWaaG sugar binding site, only hydrolyzed UDP-glucose, underscoring the importance of the identified amino acids in substrate specificity. However, neither WT PaWaaG nor the PaWaaG mutant capable of hydrolyzing UDP-glucose was able to complement an E. coli ΔwaaG strain, indicating that more remains to be uncovered about the function of PaWaaG in vivo. This structural and biochemical information will guide future structure-based drug design efforts targeting PaWaaG.
Keywords
Pseudomonas aeruginosa, WaaG, glycosyltransferase, lipopolysaccharide, X-ray crystallography, NMR
National Category
Structural Biology
Research subject
Biochemistry
Identifiers
urn:nbn:se:su:diva-220525 (URN)10.1016/j.jbc.2023.105256 (DOI)001166256400001 ()37716703 (PubMedID)2-s2.0-85173583816 (Scopus ID)
Funder
Swedish Research Council, 2022-03681Swedish Cancer Society, 20 1287 PjFNovo Nordisk Foundation, 0071844Carl Tryggers foundation , CTS 21:1637Swedish Research Council, 2022-03014Knut and Alice Wallenberg FoundationSwedish Research Council, 2018-03395
2023-08-302023-08-302024-10-02Bibliographically approved